The Cushing’s Support and Research Foundation

Leslie Edwin, President of the Cushing’s Support and Research Foundation (CSRF), and Gretchen Jordan, Associate Director of the CSRF, discuss how their organization supports patients with Cushing’s disease/syndrome.     Cushing’s syndrome is a rare...

Phase 1 Investigational Drug for Rare Blood Cancers

Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the Phase 1 clinical trial for investigational drug candidate IDP-023, to treat patients with rare blood cancers.     Non-Hodgkin lymphoma (NHL) is a group of malignant cancers originating from the...